These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 7840056
1. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Galiè N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B. Am J Cardiol; 1995 Jan 19; 75(3):55A-62A. PubMed ID: 7840056 [Abstract] [Full Text] [Related]
2. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Houde C, Bohn DJ, Freedom RM, Rabinovitch M. Br Heart J; 1993 Nov 19; 70(5):461-8. PubMed ID: 8260279 [Abstract] [Full Text] [Related]
3. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS. Chest; 2001 Sep 19; 120(3):866-72. PubMed ID: 11555522 [Abstract] [Full Text] [Related]
4. Vasodilator therapy for primary pulmonary hypertension. McGoon MD, Vlietstra RE. Mayo Clin Proc; 1984 Oct 19; 59(10):672-7. PubMed ID: 6148467 [Abstract] [Full Text] [Related]
5. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G. Circulation; 2005 Jun 14; 111(23):3105-11. PubMed ID: 15939821 [Abstract] [Full Text] [Related]
6. [Pulmonary hypertension in pediatric heart surgery]. Falcone N. Rev Esp Anestesiol Reanim; 2001 Dec 14; 48(10):462-4. PubMed ID: 11792301 [Abstract] [Full Text] [Related]
7. The United States experience with the acute and chronic treatment of primary pulmonary hypertension. Weir EK. Eur Heart J; 1988 Sep 14; 9 Suppl J():33-8. PubMed ID: 3053183 [Abstract] [Full Text] [Related]
8. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. Adnot S, Samoyeau R, Weitzenblum E. Blood Press Suppl; 1995 Sep 14; 3():47-57. PubMed ID: 8535542 [Abstract] [Full Text] [Related]
9. Drug therapy of primary pulmonary hypertension. Nagaya N. Am J Cardiovasc Drugs; 2004 Sep 14; 4(2):75-85. PubMed ID: 15049720 [Abstract] [Full Text] [Related]
10. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J. Chest; 2004 Feb 14; 125(2):580-6. PubMed ID: 14769741 [Abstract] [Full Text] [Related]
11. Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension. Ribas J, Angrill J, Barberà JA, García-Pagán JC, Roca J, Bosch J, Rodriguez-Roisin R. Eur Respir J; 1999 Jan 14; 13(1):210-2. PubMed ID: 10836350 [Abstract] [Full Text] [Related]
17. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension. Robbins IM, Christman BW, Newman JH, Matlock R, Loyd JE. Chest; 1998 Nov 14; 114(5):1269-75. PubMed ID: 9824000 [Abstract] [Full Text] [Related]
18. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications. Lim HS, Zaphiriou A. J Card Fail; 2016 Feb 14; 22(2):117-24. PubMed ID: 26547011 [Abstract] [Full Text] [Related]
19. Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Jones K, Higenbottam T, Wallwork J. Chest; 1989 Oct 14; 96(4):784-9. PubMed ID: 2507232 [Abstract] [Full Text] [Related]
20. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Tonelli AR, Alnuaimat H, Mubarak K. Respir Med; 2010 Apr 14; 104(4):481-96. PubMed ID: 20004088 [Abstract] [Full Text] [Related] Page: [Next] [New Search]